Etiket: molnupiravir
WHO recommends molnupiravir, Merck’s antiviral pill, to certain patients at risk
States are not obliged to follow this recommendation. In France, the HAS did not grant authorization for this treatment last December. Article written by Posted on 03/03/2022 11:30 Update on…
Merck’s anti-COVID pill molnupiravir cleared in US
The Merck laboratory’s COVID-19 pill, intended for high-risk adults, was urgently authorized Thursday by the United States Medicines Agency (FDA), the day after the authorization of a similar pill developed…
the High Authority for Health refuses to grant authorization for early access to molnupiravir
HAS, on the other hand, gave the green light to the use of the new monoclonal antibody treatment Evusheld, from the AstraZeneca laboratory. Article written by Posted on 12/10/2021 8:41…
What other treatments after molnupiravir may be available soon?
After the Merck laboratory and its treatment with a pill against Covid-19, molnupiravir, authorized in the United Kingdom on Thursday, November 4, the American Pfizer in turn announced, on Friday,…
UK becomes first country to approve merck laboratory treatment molnupiravir
A pill and a lot of hope. The United Kingdom announced, Thursday, November 4, to be the first country to authorize molnupiravir, a pill treatment against Covid-19 developed by the…
France has ordered 50,000 doses of “molnupiravir” produced by Merck
This pill could dTo reduce by two the risks of hospitalization for patients who have just been tested positive for Covid-19, according to the pharmaceutical group. Article written by Posted…
European Medicines Agency launches expedited review of Merck’s “molnupiravir”
If approved, this easy-to-administer remedy could become a crucial tool in the fight against the pandemic by reducing severe forms of the disease in addition to vaccination. Article written by…